Carl Ashley Morris - 14 Mar 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Scientific Officer
Signature
/s/ Erin P. Brennan as attorney-in-fact for Carl Ashley Morris
Issuer symbol
SLDB
Transactions as of
14 Mar 2022
Net transactions value
-$24,932
Form type
4
Filing time
15 Mar 2022, 17:14:35 UTC
Previous filing
31 Jan 2022
Next filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale $12,396 -11,269 -4.1% $1.10 266,605 14 Mar 2022 Direct F1, F2
transaction SLDB Common Stock Sale $12,536 -11,396 -4.3% $1.10 255,209 14 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2 Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.